An overview of the Progenika ID CORE XT: An automated genotyping platform based on a fluidic microarray system

15Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Automated testing platforms facilitate the introduction of red cell genotyping of patients and blood donors. Fluidic microarray systems, such as Luminex XMAP (Austin, TX), are used in many clinical applications, including HLA and HPA typing. The Progenika ID CORE XT (Progenika Biopharma-Grifols, Bizkaia, Spain) uses this platform to analyze 29 polymorphisms determining 37 antigens in 10 blood group systems. Once DNA has been extracted, processing time is approximately 4 hours. The system is highly automated and includes integrated analysis software that produces a file and a report with genotype and predicted phenotype results.

Cite

CITATION STYLE

APA

Goldman, M., Nogués, N., & Castilho, L. M. (2015). An overview of the Progenika ID CORE XT: An automated genotyping platform based on a fluidic microarray system. Immunohematology, 31(3), 62–68. https://doi.org/10.21307/immunohematology-2019-072

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free